Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue
about
Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinismClinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations.Role of Hsp90 in biogenesis of the beta-cell ATP-sensitive potassium channel complexEngineered Kir6.2 mutations that correct the trafficking defect of K(ATP) channels caused by specific SUR1 mutationsCongenital hyperinsulinism in Chinese patients: 5-yr treatment outcome of 95 clinical cases with genetic analysis of 55 cases.Impact of disease-causing SUR1 mutations on the KATP channel subunit interface probed with a rhodamine protection assay.Ion channel associated diseases: overview of molecular mechanismsNeonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2Syntaxin 1A regulates surface expression of beta-cell ATP-sensitive potassium channels.Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1Structurally distinct ligands rescue biogenesis defects of the KATP channel complex via a converging mechanism.Neonatal Diabetes and Congenital Hyperinsulinism Caused by Mutations in ABCC8/SUR1 are Associated with Altered and Opposite Affinities for ATP and ADPRole of Derlin-1 protein in proteostasis regulation of ATP-sensitive potassium channels.Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism.Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels.Kir6.2 activation by sulfonylurea receptors: a different mechanism of action for SUR1 and SUR2A subunits via the same residues.Galactokinase deficiency in a patient with congenital hyperinsulinismGenotype and phenotype correlations in 417 children with congenital hyperinsulinismPerspective on the Genetics and Diagnosis of Congenital Hyperinsulinism DisordersThe molecular mechanisms, diagnosis and management of congenital hyperinsulinismDecomposition of slide helix contributions to ATP-dependent inhibition of Kir6.2 channelsAn overview of trafficking and assembly of neurotransmitter receptors and ion channels (Review).Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism.Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.Leptin regulates KATP channel trafficking in pancreatic β-cells by a signaling mechanism involving AMP-activated protein kinase (AMPK) and cAMP-dependent protein kinase (PKA).Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels.Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating.Tuning the electrical properties of the heart by differential trafficking of KATP ion channel complexes.Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management.The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics.Treatment strategies for acute metabolic disorders in neonates.Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.An ABCC8 Nonsense Mutation Causing Neonatal Diabetes Through Altered Transcript Expression.Co-inheritance of two ABCC8 mutations causing an unresponsive congenital hyperinsulinism: clinical and functional characterization of two novel ABCC8 mutations.Carbamazepine inhibits ATP-sensitive potassium channel activity by disrupting channel response to MgADP.Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations.Functional and Metabolomic Consequences of KATP Channel Inactivation in Human Islets.Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM.
P2860
Q24297468-6A2B4307-B50B-42D0-8A39-22C8962C4348Q27865219-17B46A7E-56EF-4078-85AF-222BE060D349Q28566112-7AD932CF-D9B0-4F0F-AEB3-A75F40AF10F7Q28941209-49B5A128-84E2-4B29-9D13-949D61927B1AQ33420097-E4AE948C-7329-4685-985F-333D77E41C7AQ33661454-79BA6113-06FC-4F88-8196-DF9E7C494D5AQ34311621-7C1E873A-2FB7-4178-B710-75D43BFED0CCQ34395436-9B2140F2-CBAC-49BF-A869-1C30352C7510Q34618893-32D64484-B759-4E53-B9A3-00429212499CQ34718049-1113D0CF-A517-41C5-84BB-C19FD533EAD7Q35043418-F996ACD3-161B-407F-8E99-7C880F8FD938Q35199497-BAA06DE7-E045-45B0-889E-67EAE40E685CQ35427798-D8424703-CC1F-42D4-99E3-80C2C099816DQ35880004-BA96517E-1EE6-4262-BFCA-A9DFBC0B4470Q36042053-04CCF5DC-F263-452F-97FF-6454DF9654E4Q36130308-549366EC-6016-4384-A0DD-941ECDA00F5AQ36144528-DF8564AA-2FB4-4668-9153-CADCC381CC72Q36433456-4EC138A6-D2A3-4A5C-9C8D-5D69C67B63F8Q36589427-2D5C9C85-FE5C-4A32-B746-0BA6A7B2DDACQ36716020-657E94ED-5E67-4962-8C9E-95D73F651701Q36862232-3E195302-E29C-4CF2-B387-DE6BCD442082Q37095382-41D5258D-B3BC-4523-B0F7-E679E80F1EBBQ37150909-317FCE81-3E98-4B01-AD5F-1A6ABE69695EQ37175099-EA6844D0-513A-43FE-8213-16EF7E996321Q37259401-97EB6681-3844-4EC4-A1DF-1F48BA5F0FDDQ37333827-48FD38DB-576A-4F53-8576-0F5B5E5892B9Q37409971-AD6C13A0-F82F-408A-A117-989D78B03267Q37691747-E11B796B-F938-4AE1-BB49-32DAB6920455Q37733013-2C3F10DD-94AD-4644-8E65-48EDE2321C4EQ37974513-AC38CE3C-0286-4260-AF4C-3240718A6F7DQ38869442-B39815EB-60C1-43C9-9B5A-9BE35E9FFA2FQ38919295-50821A5E-51EB-4964-ABD3-D09C82B76111Q39261263-CD15BA2F-4B35-42A0-B0B8-5CE40CDFF973Q39893899-23CF0B5B-A01D-421F-A984-174AC837A4F8Q41156451-685FABE7-FE5A-410F-8359-57EDC73C6534Q41994670-0845D5F0-33C9-4AD8-A146-E6D93E00638BQ42183070-70CE8B8A-C760-4275-8297-2777ECF35019Q42383191-D5249151-6A9D-4E62-A4C3-78B3BE8470E4Q42508897-073953B1-D8CD-4B34-BB88-F2A0B02569E2Q42637813-316E8D7E-12CE-4985-A94B-16E494E316E3
P2860
Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Congenital hyperinsulinism ass ...... els: identification and rescue
@ast
Congenital hyperinsulinism ass ...... els: identification and rescue
@en
type
label
Congenital hyperinsulinism ass ...... els: identification and rescue
@ast
Congenital hyperinsulinism ass ...... els: identification and rescue
@en
prefLabel
Congenital hyperinsulinism ass ...... els: identification and rescue
@ast
Congenital hyperinsulinism ass ...... els: identification and rescue
@en
P2093
P2860
P356
P1433
P1476
Congenital hyperinsulinism ass ...... els: identification and rescue
@en
P2093
Arupa Ganguly
Courtney MacMullen
Fei-Fei Yan
Show-Ling Shyng
Yu-Wen Lin
P2860
P304
P356
10.2337/DB07-0150
P407
P577
2007-06-15T00:00:00Z